Literature DB >> 26936808

Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer.

Tatsuto Nishigori1, Hiroshi Okabe1,2, Eiji Tanaka1,3, Shigeru Tsunoda1, Shigeo Hisamori1, Yoshiharu Sakai1.   

Abstract

BACKGROUND AND OBJECTIVES: Sarcopenia or loss of skeletal muscle mass has been identified as a poor prognostic factor for a wide variety of diseases and conditions. We investigated whether preoperative sarcopenia is associated with postoperative complications in patients undergoing esophagectomy for thoracic esophageal cancer.
METHODS: We retrospectively reviewed the medical records of consecutive patients with thoracic esophageal cancer who underwent esophagectomy between September 2005 and July 2014 at Kyoto University Hospital. Skeletal muscle mass was assessed using preoperative computed tomographic scans by measuring the cross-sectional muscle area at the third lumbar vertebral level.
RESULTS: Among the 199 eligible patients, 149 (75%) were classified as having sarcopenia. There was no difference in the incidence of overall complications between the groups (risk ratio [RR]: 1.10, 95% confidence interval [CI]: 0.80-1.53, P = 0.54). However, pulmonary complications were significantly more frequent in the sarcopenia group than in the nonsarcopenia group (RR: 2.63, 95% CI: 1.20-5.77, P = 0.007). Multivariate analyses demonstrated that sarcopenia was associated with a high adjusted risk of one or more pulmonary complications (odds ratio: 2.96, 95% CI: 1.14-7.69, P = 0.026).
CONCLUSIONS: Sarcopenia independently predicts pulmonary complications after esophagectomy for thoracic esophageal cancer. J. Surg. Oncol. 2016;113:678-684.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sarcopenia; esophageal neoplasms; pneumonia; postoperative complications; risk factors

Mesh:

Year:  2016        PMID: 26936808     DOI: 10.1002/jso.24214

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  34 in total

1.  Association Between Sarcopenia and Mortality in Patients Undergoing Surgical Excision of Head and Neck Cancer.

Authors:  Lucas Stone; Brennan Olson; Alia Mowery; Stephanie Krasnow; Angie Jiang; Ryan Li; Joshua Schindler; Mark K Wax; Peter Andersen; Daniel Marks; Virginie Achim; Daniel Clayburgh
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

2.  Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy.

Authors:  Yohei Ozawa; Toru Nakano; Yusuke Taniyama; Tadashi Sakurai; Yu Onodera; Kurodo Kamiya; Makoto Hikage; Chiaki Sato; Kai Takaya; Takuro Konno; Michiaki Unno; Takashi Kamei
Journal:  Esophagus       Date:  2019-04-12       Impact factor: 4.230

3.  Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?

Authors:  Hiroshi Saeki; Yuichiro Nakashima; Kensuke Kudou; Shun Sasaki; Tomoko Jogo; Kosuke Hirose; Keitaro Edahiro; Shotaro Korehisa; Daisuke Taniguchi; Ryota Nakanishi; Nobuhide Kubo; Koji Ando; Akira Kabashima; Eiji Oki; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

4.  Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis.

Authors:  Pei-Yu Wang; Li-Dong Xu; Xian-Kai Chen; Lei Xu; Yong-Kui Yu; Rui-Xiang Zhang; Hai-Bo Sun; Hui-Li Wu; Yin Li
Journal:  Ann Surg Oncol       Date:  2020-02-10       Impact factor: 5.344

5.  Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy.

Authors:  Sho Sato; Chikara Kunisaki; Hideaki Suematsu; Yusaku Tanaka; Hiroshi Miyamoto; Takashi Kosaka; Norio Yukawa; Kuniya Tanaka; Kei Sato; Hirotoshi Akiyama; Itaru Endo
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

6.  Sarcopenia does not affect postoperative complication rates in oesophageal cancer surgery: a systematic review and meta-analysis.

Authors:  D Schizas; M Frountzas; I Lidoriki; E Spartalis; K Toutouzas; D Dimitroulis; T Liakakos; K S Mylonas
Journal:  Ann R Coll Surg Engl       Date:  2019-09-11       Impact factor: 1.891

7.  Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance.

Authors:  Emer M Guinan; S L Doyle; A E Bennett; L O'Neill; J Gannon; J A Elliott; J O'Sullivan; J V Reynolds; J Hussey
Journal:  Support Care Cancer       Date:  2017-12-02       Impact factor: 3.603

Review 8.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

9.  Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010-2015.

Authors:  Sofia Altuna-Venegas; Raul Aliaga-Vega; Jorge L Maguiña; Jose F Parodi; Fernando M Runzer-Colmenares
Journal:  Arch Gerontol Geriatr       Date:  2019-01-29       Impact factor: 3.250

10.  Effects of preoperative sarcopenia on postoperative complications of minimally invasive oesophagectomy for oesophageal squamous cell carcinoma.

Authors:  Jinxin Xu; Bin Zheng; Shuliang Zhang; Taidui Zeng; Hao Chen; Wei Zheng; Chun Chen
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.